Full Sales and Support services for the entire line of computational technology products (Rametrix® Chemometric Analysis, Rametrix® Molecular Urinalysis, The Rametrix® Specimen Database) and devices (Rametrix® AutoScanner V2.0, ProofMed-CS™ Controlled Substance Management System, ProofMed-CH™ Chemotherapy Management System) will be offered in the Third Quarter of 2023, as we introduce our products and devices to the market.